Vanda Pharmaceuticals Inc (NASDAQ:VNDA)

9.90
Delayed Data
As of Apr 17
 -0.19 / -1.88%
Today’s Change
8.34
Today|||52-Week Range
16.50
-30.87%
Year-to-Date
No recent news for Vanda Pharmaceuticals Inc.

Today’s Trading

Previous close10.09
Today’s open10.05
Day’s range9.67 - 10.05
Volume364,822
Average volume (3 months)783,872
Market cap$412.2M
Dividend yield--
Data as of 3:59pm ET, 04/17/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+40.35%
Earnings growth (next 5 years)+19.10%
Revenue growth (last year)+48.05%
P/E ratio18.0
Price/Sales9.93
Price/Book2.55

Competitors

 Today’s
change
Today’s
% change
SRNESorrento Therapeutic...+0.16+1.43%
PRTKParatek Pharmaceutic...-1.18-3.99%
AMPEAmpio Pharmaceutical...-0.10-1.25%
IDRAIdera Pharmaceutical...-0.14-3.90%
Data as of 4:03pm ET, 04/17/2015

Financials

Next reporting dateMay 7, 2015
EPS forecast (this quarter)-$0.33
Annual revenue (last year)$50.2M
Annual profit (last year)$20.2M
Net profit margin40.25%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mihael Hristos Polymeropoulos
CFO, Secretary, Treasurer &
Senior Vice President
James Patrick Kelly
Corporate headquarters
Washington, District Of Columbia

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers